ENVB
Price
$1.11
Change
-$0.00 (-0.00%)
Updated
Aug 8 closing price
Capitalization
2.74M
ORMP
Price
$2.09
Change
+$0.01 (+0.48%)
Updated
Aug 8 closing price
Capitalization
85.37M
3 days until earnings call
Interact to see
Advertisement

ENVB vs ORMP

Header iconENVB vs ORMP Comparison
Open Charts ENVB vs ORMPBanner chart's image
Enveric Biosciences
Price$1.11
Change-$0.00 (-0.00%)
Volume$56.46K
Capitalization2.74M
Oramed Pharmaceuticals
Price$2.09
Change+$0.01 (+0.48%)
Volume$36.47K
Capitalization85.37M
ENVB vs ORMP Comparison Chart in %
Loading...
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENVB vs. ORMP commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENVB is a Hold and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 10, 2025
Stock price -- (ENVB: $1.11 vs. ORMP: $2.09)
Brand notoriety: ENVB and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENVB: 36% vs. ORMP: 52%
Market capitalization -- ENVB: $2.74M vs. ORMP: $85.37M
ENVB [@Biotechnology] is valued at $2.74M. ORMP’s [@Biotechnology] market capitalization is $85.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENVB’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • ENVB’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than ENVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENVB’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • ENVB’s TA Score: 3 bullish, 6 bearish.
  • ORMP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both ENVB and ORMP are a bad buy in the short-term.

Price Growth

ENVB (@Biotechnology) experienced а -3.48% price change this week, while ORMP (@Biotechnology) price change was -1.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($85.4M) has a higher market cap than ENVB($2.74M). ORMP YTD gains are higher at: -13.636 vs. ENVB (-79.353). ENVB has higher annual earnings (EBITDA): -9.01M vs. ORMP (-21.53M). ORMP has more cash in the bank: 131M vs. ENVB (4.29M). ENVB has less debt than ORMP: ENVB (0) vs ORMP (301K). ORMP has higher revenues than ENVB: ORMP (2M) vs ENVB (0).
ENVBORMPENVB / ORMP
Capitalization2.74M85.4M3%
EBITDA-9.01M-21.53M42%
Gain YTD-79.353-13.636582%
P/E RatioN/A20.91-
Revenue02M-
Total Cash4.29M131M3%
Total Debt0301K-
FUNDAMENTALS RATINGS
ENVB vs ORMP: Fundamental Ratings
ENVB
ORMP
OUTLOOK RATING
1..100
5664
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
9175
P/E GROWTH RATING
1..100
10047
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENVB's Valuation (14) in the Electronics Or Appliances industry is somewhat better than the same rating for ORMP (57) in the Pharmaceuticals Other industry. This means that ENVB’s stock grew somewhat faster than ORMP’s over the last 12 months.

ENVB's Profit vs Risk Rating (100) in the Electronics Or Appliances industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that ENVB’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that ORMP’s stock grew similarly to ENVB’s over the last 12 months.

ORMP's Price Growth Rating (75) in the Pharmaceuticals Other industry is in the same range as ENVB (91) in the Electronics Or Appliances industry. This means that ORMP’s stock grew similarly to ENVB’s over the last 12 months.

ORMP's P/E Growth Rating (47) in the Pharmaceuticals Other industry is somewhat better than the same rating for ENVB (100) in the Electronics Or Appliances industry. This means that ORMP’s stock grew somewhat faster than ENVB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENVBORMP
RSI
ODDS (%)
Bullish Trend 5 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SINT2.890.21
+7.64%
SiNtx Technologies Inc.
ATGE121.842.61
+2.19%
Adtalem Global Education
WHWK1.750.03
+1.74%
Whitehawk Therapeutics Inc
AEG7.380.10
+1.37%
Aegon Ltd
IVA3.58-0.06
-1.65%
Inventiva SA

ENVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENVB has been loosely correlated with PRQR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ENVB jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENVB
1D Price
Change %
ENVB100%
N/A
PRQR - ENVB
43%
Loosely correlated
+5.85%
ALNY - ENVB
36%
Loosely correlated
+0.88%
ORMP - ENVB
33%
Poorly correlated
+0.48%
SLNCF - ENVB
28%
Poorly correlated
N/A
ARCT - ENVB
27%
Poorly correlated
-0.58%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.48%
BTAI - ORMP
44%
Loosely correlated
+18.48%
INO - ORMP
44%
Loosely correlated
-2.08%
MBIO - ORMP
44%
Loosely correlated
+9.21%
ZNTL - ORMP
43%
Loosely correlated
-0.69%
RVMD - ORMP
42%
Loosely correlated
+0.17%
More